inABLE<sup>®</sup> technology helps unlock the secrets of cyclic peptides

Ingenza is using its proprietary inABLE® technology to help develop a robust, versatile platform for the production of cyclic peptides for therapeutic use. This work is part of a collaboration with researchers at the University of Aberdeen and the University…